Newsroom

DALLAS--(BUSINESS WIRE)--Verily today announced a $300 million investment round led by Series X Capital, with participation from Alphabet, UCHealth, the University of Colorado Anschutz and other investors, to advance the next phase of its precision health AI strategy. With this funding round, Alphabet will be a significant minority investor in Verily, while no longer having a controlling stake. “Today is an important step in our mission to bring the promise of precision health to everyone,” sai...

LONDON--(BUSINESS WIRE)--  Re: Nordic Investment Bank EUR 10,000,000.00 MATURING: 21-Dec-2027 ISIN: XS2569312577 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 23-Mar-2026 TO 22-Jun-2026 HAS BEEN FIXED AT 3.11 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 22-Jun-2026 WILL AMOUNT TO: EUR 510,661.67 PER EUR 65,000,000.00 DENOMINATION  ...

PALO ALTO, Calif.--(BUSINESS WIRE)--RecVue, il leader nelle piattaforme di gestione della fatturazione e dei ricavi basate sull'intelligenza artificiale per la monetizzazione aziendale complessa, oggi ha annunciato di aver completato l'acquisizione di AiVidens. Rilevando la piattaforma di gestione della liquidità e degli incassi, RecVue consentirà alle aziende di passare oltre la semplice automazione per unificare la gestione dei contratti, la fatturazione, gli incassi, la conformità dei ricavi...

DALLAS--(BUSINESS WIRE)--The M&A Advisor announced the winners of the 20th Annual Turnaround Awards, and Riveron, a leading advisory firm providing mission-critical services to the office of the CFO, private equity firms, and other capital providers, was named a winner in two categories: Distressed M&A Deal of the Year ($100MM to $250MM) for the Sale and Reorganization of Edgio, Inc. Cross-Border Restructuring of the Year (Over $1B) for the Restructuring of WOM Chile (aka NC Telecom II)...

LONDON--(BUSINESS WIRE)--  Re: NATWEST Markets PLC USD 185,600,000.00 MATURING: 21-Mar-2030 ISIN: US63906YAQ17 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Dec-2025 TO 23-Mar-2026 HAS BEEN FIXED AT 4.88 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 23-Mar-2026 WILL AMOUNT TO: USD 1,256,697.67 PER USD 101,908,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: NATWEST Markets PLC USD 330,580,000.00 MATURING: 21-Mar-2028 ISIN: US63906YAN85 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Dec-2025 TO 23-Mar-2026 HAS BEEN FIXED AT 4.64 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 23-Mar-2026 WILL AMOUNT TO: USD 3,758,455.61 PER USD 320,550,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: Lloyds Bank Corporate Markets plc EUR 350,000,000.00 MATURING: 22-Sep-2028 ISIN: XS3186892025 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 23-Mar-2026 TO 22-Jun-2026 HAS BEEN FIXED AT 2.61 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 22-Jun-2026 WILL AMOUNT TO: EUR 659.24 PER EUR 100,000.00 DENOMINATION  ...

NEW YORK--(BUSINESS WIRE)--KBRA assigns a preliminary rating to one class of notes issued by AMCR ABS Trust 2026-A (“AMCR 2026-A”), an unsecured consumer loan ABS transaction. AMCR 2026-A has initial hard credit enhancement of 44.2% for the Class A notes. Credit enhancement is comprised of overcollateralization, subordination (except for the Class D notes), a cash reserve account funded at closing, and excess spread. AMCR 2026-A will issue four classes of notes totaling $149.3 million, with KBR...

PALO ALTO, Californie--(BUSINESS WIRE)--RecVue, leader des plateformes de facturation et de gestion des revenus alimentées par l'IA pour la monétisation d'entreprises complexes, annonce aujourd'hui avoir finalisé l'acquisition d'AiVidens. Grâce à cette acquisition, RecVue permettra aux entreprises d'aller au-delà de la simple automatisation des revenus et d'unifier la gouvernance des contrats, la facturation, le recouvrement, la conformité des revenus, le partage des revenus et la gestion de la...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA). If you currently own shares of Verrica Pharmaceuticals stock, please visit the firm’s website at https://rosenlegal.com/submit-form/?case_id=6828 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at case@rosenleg...